Suicide barrier fails to stop overall suicide rates: Researchers

Research: Effect of a barrier at Bloor Street Viaduct on suicide rates in Toronto: natural experiment

Suicide barriers on bridges might not reduce overall suicide rates by jumping from heights, as people may change location for their suicide attempt, according to a new study published on bmj.com today.

Researchers from Canada found that the overall suicide rate (by any means) in Toronto reduced after a barrier was erected at one particular bridge known for a high suicide rate, but suicides from jumping remained the same.

Restricting peoples' access to a means of suicide can delay and prevent suicide such as in the UK where switching to carbon monoxide-free sources of gas was successful in reducing suicide numbers.

Suicide barriers erected to prevent jumping have been established at the Empire State Building in the USA, the Eiffel Tower in France, and bridges worldwide. No study so far, however, has shown that a suicide barrier has led to a statistically significant drop in overall suicide rates in an area.

Researchers from Toronto studied the impact of the erection of a suicide barrier at the Bloor Street Viaduct, the bridge with the world's second highest annual rate of suicide by jumping after Golden Gate Bridge in San Francisco.

The barrier was constructed between April 2002 and June 2003. Prior to that, there was an average of 10 suicides a year by jumping from the bridge between 1992 and 2002.

The researchers studied data covering all suicides in Ontario during the period 1 January 1993 to 30 June 2007. They classified the nine years from 1993 to 2001 as being before the barrier and the four years from July 1 2003 to June 30 2007 as being after the barrier.

Results showed that suicide deaths at the Bloor Street Viaduct fell from 9.3 per year before the barrier to zero after it was constructed.

However, there was no impact on suicide by jumping in the region as a whole. Toronto's overall yearly suicide rate by jumping was almost unchanged when comparing the pre and post barrier periods at 56.4 per year compared to 56.6 per year.

It was also noted that, post-barrier in Toronto, there was a statistically significant increase in suicides by jumping from bridges other than the Bloor Street Viaduct (8.7 suicide rate per year rising to 14.2 per year).

There was, however, a decrease in both the overall rate of suicides in Toronto and the rate of suicides by means other than jumping in the post-barrier period.

The researchers conclude: "This research shows that constructing a barrier on a bridge with a high rate of suicide by jumping is likely to reduce or eliminate suicides at that bridge but it may not alter absolute suicide rates by jumping when there are comparable bridges nearby."

"This study reminds us that means restriction may not work everywhere, and that we have much to learn about the determinants of the choice of method in suicidal acts," writes David Gunnell from the University of Bristol and Matthew Miller from Harvard School of Public Health, in an accompanying editorial.

"Yet, where and when means restriction works, it may save more lives than other suicide prevention strategies, especially in children and young adults, who tend to act impulsively in fleeting suicidal crisis," they conclude.

Comments

  1. DF H DF H United States says:

    Instead of building a society that inspires more hope we try to bar the exits so those who want to escape must jump out windows rather than open doors.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Patient-derived organoids: Transforming cancer research and personalized medicine